Table 2.
Group mean resting BP and HR results pre and post 4-week intervention
| Variable | CON | HR-EX | RPE-EX | |||
|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | |
| Seated resting measurements | ||||||
| SBP (mmHg) | 128.6 ± 8.5 | 127.0 ± 11.0 | 134.0 ± 4.0†† | 119.8 ± 5.8** | 125.1 ± 5.3†† | 116.0 ± 3.8** |
| DBP (mmHg) | 80.6 ± 7.0 | 80.4 ± 8.0 | 82.6 ± 5.3 | 76.2 ± 5.7** | 77.3 ± 8.4 | 71.2 ± 7.6** |
| MAP (mmHg) | 98.2 ± 8.3 | 97.4 ± 9.1 | 101.2 ± 3.0† | 92.9 ± 4.3** | 94.4 ± 4.4† | 88.3 ± 4.1** |
| HR (b.min−1) | 64.3 ± 7.1 | 64.6 ± 9.1 | 62.5 ± 7.3 | 62.1 ± 10.5 | 71.5 ± 16.7 | 67.0 ± 11.3 |
| Supine resting measurements | ||||||
| SBP (mmHg) | 113.9 ± 11.8 | 115.1 ± 10.7 | 124.9 ± 11.2 | 119.1 ± 10.7* | 115.3 ± 5.6 | 107.9 ± 5.3** |
| DBP (mmHg) | 69.2 ± 13.3 | 70.0 ± 12.0 | 77.9 ± 5.8† | 74.2 ± 6.4*† | 70.1 ± 3.7† | 62.0 ± 5.3**† |
| MAP (mmHg) | 85.8 ± 11.0 | 87.1 ± 9.7 | 94.4 ± 6.8 | 89.7 ± 7.3* | 87.8 ± 2.9 | 79.4 ± 4.8** |
| HR (b.min−1) | 57.8 ± 4.9 | 57.8 ± 4.7 | 57.9 ± 7.0 | 57.6 ± 9.0 | 58.8 ± 9.6 | 57.4 ± 9.5 |
*P < 0.05
**P < 0.001 significant with-in group differences
†P < 0.05
††P < 0.001 significant difference compared to the other intervention group at the same time-point